|
UROLOGICAL
ONCOLOGY
Tumor
seeding in urological laparoscopy: an international survey
Micali S, Celia A, Bove P, De Stefani S, Sighinolfi MC, Kavoussi LR, Bianchi
G
Department of Urology, University of Modena e Reggio Emilia, Modena, Italy
J Urol. 2004; 171: 2151-4
-
Purpose: During
the last 10 years laparoscopy has been applied to treat most urological
pathology including malignancies. There has been concern regarding peritoneal
dissemination and port site metastases. We undertook a survey to assess
the incidence of this occurrence.
-
Materials and Methods:
A total of 50 international urology departments with experts in laparoscopic
urological surgery were contacted for this study. Each site was asked
to complete a 2-page survey regarding the volume of laparoscopic urological
procedures and port site recurrences.
-
Results: Nineteen
sites elected to participate. A total of 18750 laparoscopic procedures
were performed, of which 10912 were for cancer. These included 2604
radical nephrectomies, 559 nephroureterectomies, 555 partial nephrectomies,
27 segmental ureterectomies, 3665 radical prostatectomies, 1869 pelvic
lymph node dissections, 479 retroperitoneal lymph node dissections,
336 adrenalectomies and 108 procedures listed as other. Tumor seeding
was reported in 13 cases (0.1%), including 3 nephroureterectomies for
transitional cell carcinoma, 4 nephrectomies (incidental transitional
cell carcinoma), 4 adrenalectomies for metastases, 1 retroperitoneal
lymph node dissection for testicular cancer and 1 pelvic lymph node
dissection for cancer of the penis. Port seeding occurred in 10 cases
(0.09%) and peritoneal spread in 3 cases (0.03%).
-
Conclusions:
The incidence of tumor seeding after laparoscopic oncological surgery
is rare and does not appear greater than what has been historically
reported for open surgery. Tumor seeding seems to be most commonly related
to the removal of high grade tumors and deviation from oncological surgical
principles.
- Editorial
Comment
Laparoscopic surgery has evolved to a reliable and safe procedure in
urology – if indicated correctly. This paper shows the safety
of the procedure in regard to oncological procedures.
Two facts however deserve emphasis and should be kept in mind. First,
patients with port metastases might not return to the surgeon or the
center where the initial procedure was undertaken, so a certain number
of non-reporting is certain. Second, the majority of implantation metastases
(n = 7) stems from transitional cancer. This tumor entity therefore
might be considered hazardous for laparoscopic procedures and open surgery
might be preferable here.
Dr. Andreas Böhle
Professor of Urology
HELIOS Agnes Karll Hospital
Bad Schwartau, Germany
|